Crossmark Global Holdings, Inc.

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1539204 HOUSTON, TX

Position in LKFT

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$315,929

-$662,281 QoQ

Shares Held

10,538

-67.7% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 78 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Crossmark Global Holdings, Inc. holds $48,601,060 across 36 Biotechnology names. LKFT ranks #27 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	89,139	$10,104,797
2	ARGX	Argenx SE	9,684	$8,984,524
3	EXEL	Exelixis, Inc.	74,817	$4,070,792
4	ONC	BeOne Medicines Ltd.	10,755	$3,064,852
5	BMRN	Biomarin Pharmaceutical Inc	51,220	$2,930,808
6	BNTX	BioNTech SE	20,934	$1,947,908
7	JAZZ	Jazz Pharmaceuticals plc	7,237	$1,743,899
8	VRTX	Vertex Pharmaceuticals Inc / Ma	2,828	$1,404,752

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$315,929	10,538	-67.7%	Shares	Sole	2026-07-16
2026-03-31	$978,210	32,607	-1.1%	Shares	Sole	2026-05-11
2025-12-31	$1,078,347	32,977	+0.2%	Shares	Sole	2026-02-03
2025-09-30	$1,139,552	32,897	-30.7%	Shares	Sole	2025-11-12
2025-06-30	$1,327,901	47,442	-3.8%	Shares	Sole	2025-08-08
2025-03-31	$1,239,219	49,332	+0.3%	Shares	Sole	2025-04-30
2024-12-31	$1,351,982	49,163	+31.5%	Shares	Sole	2025-01-16
2024-09-30	$1,076,342	37,386	+582.7%	Shares	Sole	2024-11-04
2021-03-31	$422,144	5,476	-0.4%	Shares	Sole	2021-04-15
2020-12-31	$544,390	5,500	+10.7%	Shares	Sole	2021-01-14
2020-09-30	$705,292	4,970	+6.2%	Shares	Sole	2020-10-08
2020-06-30	$923,317	4,680	+6.7%	Shares	Sole	2020-08-14
2020-03-31	$859,305	4,386	—	Shares	Sole	2020-04-28
No filing history on record for this holder in this stock.